Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1353-1363

  Sierra, J ^a   Brunet, S ^a   Granena A ^a   Olive T ^a   Bueno, J ^a   Ribera, J M ^a   Petit, J ^a   Besses, C ^a   Llorente, A ^a   Guardia, R ^a   Macia J ^a   Rovira, M ^a   Badell, I ^a   Vela, E ^a   Diaz de Heredia C ^a   Vivancos, P ^a   Carreras, E ^a   Feliu, E ^a   Montserrat, E ^a   Julia A ^a   Cubells, J ^a   Rozman, C ^a   Domingo, A ^a   Ortega, J J ^a   more..

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; DOSE RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 9244263533     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1353     Document Type: Article

References (42)

1. Ganser A, Hoelzer D: Acute leukemia. Curr Opin Hematol 1:248-255, 1994
2. Stone RM, Mayer RJ: Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. Hematol Oncol Clin North Am 7:47-64, 1993
3. Buchner T: Acute leukemia. Curr Opin Hematol 1:172-182, 1993
4. Feig SA, Lampkin B, Nesbit ME, et al: Outcome of BMT during first complete remission of AML: A comparison of two sequential studies by the Childrens Cancer Group. Bone Marrow Transplant 12:65-71, 1993
5. Christiansen NP: Allogeneic bone marrow transplantation for the treatment of adult acute leukemias. Hematol Oncol Clin North Am 7:177-200, 1993
6. Champlin RE, Ho WG, Gale RP, et al: Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 103:285-291, 1985
7. Reiffers J, Gaspard MH, Maraninchi D, et al: Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukemia in first remission: A prospective controlled trial. Br J Haematol 72:57-63, 1989
8. Löwenberg B, Verdonck LJ, Dekker AW, et al: Autologous bone marrow transplantation in acute myeloid leukemia in first remission: Results of a Dutch prospective study. J Clin Oncol 8:287-294, 1990
9. Willemze R, Fibbe WE, Kluin-Nelemans JC, et al: Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia. Ann Hematol 62:59-63, 1991
10. Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL: Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 10:41-46, 1992
11. Zittoun R, Mandelli F, Willemze R, et al: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217-223, 1995
12. Harousseau JL, Pignon B, Cahn JY: Comparaison de l'autogreffe de moelle osseuse et de la chimiotherapie comme traitement d'entretien de la remission complete dans les LAM de l'adulte. Nouv Rev Fr Hematol 35:197-198, 1993
13. Mayer RJ, Davis RB, Schiffer CA, et al: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903, 1994
14. Gorin NC, Aegerter P, Auvert B, et al: Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: A European survey of the role of marrow purging. Blood 75:1606-1614, 1990
15. Gorin NC, Labopin M, Meloni G, et al: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: Further evidence of the role of marrow purging by mafosfamide. Leukemia 5:896-904, 1991
16. Bortin MM, Horowitz MM, Rowlings PA, et al: 1993 Progress report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 12:97-104, 1993
17. Sierra J, Grañena A, Bosch F, et al: Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: Response to treatment and factors influencing outcome. Hematol Oncol 10:301-309, 1992
18. Martiat P, Ghilain JM, Ferrant A, et al: High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukemia: A prospective randomized study. Eur J Haematol 45:164-167, 1990
19. Proposed revised criteria for the clasification of acute myeloid leukemia. A report of the French-American-British Cooperative group. Ann Intern Med 103:629-639, 1985
20. Bennett JM, Catovsky D, Daniel MT, et al: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 78:325-329, 1991
21. Storb R, Deeg J, Pepe M, et al: Graft-versus host disease prevention by methotrexate combined with cyclosporine compared to methotrexate alone in patients given bone marrow grafts for severe aplastic anemia: Long-term follow up of a controlled trial. Br J Haematol 72:567-572, 1989
22. Cheson BD, Cassileth PA, Head DR, et al: Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813-819, 1990
23. Clift R, Goldman J, Gratwohl A, et al: Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. Bone Marrow Transplant 4:445-448, 1989
24. Armitage P: Statistical Methods in Medical Research. Oxford, United Kingdom, Blackwell Scientific, 1971
25. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
27. Dixon WJ (ed): BMDP Statistical Software. Berkeley, CA, University of California, 1983
28. Wolff SN, Marion J, Stein RS, et al: High-dose cytosine arabinoside and daunorrubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: A pilot study. Blood 65:1407-1411, 1985
29. Tricot G, Boogaerts MA, Vlietinck R, et al: The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia. Br J Haematol 66:17-44, 1987
30. Kurrle E, Ehninger G, Freund M, et al: A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Blut 56:233-236, 1988
31. Sierra J, Grañena A, García J, et al: Autologous bone marrow transplantation for acute leukemia: Results and prognostic factors in 90 consecutive patients. Bone Marrow Transplant 12:517-523, 1993
32. Spinolo JA, Dicke KA, Horwitz LJ, et al: Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemia. Bone Marrow Transplant 5:111-118, 1990
33. Bishop JF, Lowenthal RM, Joshua D, et al: Etoposide in acute non-lymphocytic leukemia. Blood 75:27-32, 1990
34. Buchner T, Hiddemann W: Treatment strategies in acute myeloid leukemia. A. First-line chemotherapy. Blut 60:61-67, 1990
35. Cassileth PA, Begg CB, Silber R, et al: Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia. Cancer Treat Rep 71:137-140, 1987
36. Appelbaum FR, Dahlberg S, Thomas ED, et al: Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. Ann Intern Med 101:581-588, 1984
37. Berman E, Little C, Gee T, et al: Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. N Engl J Med 326:156-160, 1992
38. Ferrant A, Doyen C, Delannoy A, et al: Allogeneic or autologous bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant 7:303-309, 1991
39. Jourdan E, Maraninchi D, Reiffers J, et al: Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (less than 100 days). Leukemia 9:1068-1071, 1995
40. 3). Bone Marrow Transplant 14:293-298, 1994
41. Fenaux P, Le Deley MC, Castaigne S, et al: Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 82:3241-3249, 1993
42. Gale RP, Horowitz MM, Weiner RS, et al: Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 16:203-208, 1995